Gregory J. Cost
25Patents
8h-index
22Co-inventors
71Inventor score
Filing activity: Jul 2, 2008 → Apr 2, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7914796B2 | Engineered cleavage half-domains | Chemistry; Metallurgy | 128 | Active |
| US9873894B2 | Methods and compositions for treatment of a genetic condition | Chemistry; Metallurgy | 75 | Active |
| US9005973B2 | Targeted genomic modification with partially single-stranded donor molecules | Chemistry; Metallurgy | 59 | Active |
| US9616090B2 | Gene correction of SCID-related genes in hematopoietic stem and progenitor cells | Human Necessities | 42 | Active |
| US9902974B2 | Methods and compositions for treatment of a genetic condition | Chemistry; Metallurgy | 28 | Active |
| US9222105B2 | Methods and compositions for modification of the HPRT locus | Chemistry; Metallurgy | 15 | Active |
| US10196651B2 | Methods and compositions for treatment of a genetic condition | Chemistry; Metallurgy | 13 | Active |
| US10196652B2 | Methods and compositions for treatment of a genetic condition | Chemistry; Metallurgy | 11 | Active |
| US9970028B2 | Targeted genomic modification with partially single-stranded donor molecules | Chemistry; Metallurgy | 8 | Active |
| US7919313B2 | Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT8) gene expression | Chemistry; Metallurgy | 6 | Active |
| US8895264B2 | Methods and compositions for modification of the HPRT locus | Chemistry; Metallurgy | 6 | Active |
| US9255259B2 | Targeted genomic modification with partially single-stranded donor molecules | Chemistry; Metallurgy | 5 | Active |
| US9816074B2 | Methods and compositions for modulating nuclease-mediated genome engineering in hematopoietic stem cells | Chemistry; Metallurgy | 5 | Active |
| US9833479B2 | Gene correction of SCID-related genes in hematopoietic stem and progenitor cells | Human Necessities | 4 | Active |
| US10435677B2 | Genetically modified human cell with a corrected mutant sickle cell mutation | Chemistry; Metallurgy | 4 | Active |
| US10179918B2 | Methods and compositions for increasing transgene activity | Chemistry; Metallurgy | 3 | Active |
| US9322036B2 | Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT8) gene expression | Chemistry; Metallurgy | 2 | Active |
| US8772025B2 | Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT8) gene expression | Chemistry; Metallurgy | 1 | Active |
| US9650648B2 | Methods and compositions for treatment of a genetic condition | Chemistry; Metallurgy | 1 | Active |
| US10889834B2 | Methods and compositions for enhancing targeted transgene integration | Chemistry; Metallurgy | 0 | Active |
| US10174331B2 | Methods and compositions for nuclease-mediated targeted integration of transgenes | Emerging Cross-Sectional Technologies | 0 | Active |
| US10883119B2 | Methods and compositions for delivery of biologics | Chemistry; Metallurgy | 0 | Active |
| US9963715B2 | Methods and compositions for treatment of a genetic condition | Chemistry; Metallurgy | 0 | Active |
| US9890395B2 | Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT8) gene expression | Chemistry; Metallurgy | 0 | Active |
| US11492643B2 | Methods and compositions for treatment of a genetic condition | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.